{"id":365,"date":"2011-05-15T20:42:13","date_gmt":"2011-05-15T20:42:13","guid":{"rendered":"https:\/\/blogs.bmj.com\/sti\/?p=365"},"modified":"2011-05-15T20:42:13","modified_gmt":"2011-05-15T20:42:13","slug":"is-african-hsv-2-different","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/","title":{"rendered":"Is African HSV-2 different ?"},"content":{"rendered":"<p>Still on the topic of HSV-2 &#8230;  A clinically effective vaccine has yet to be achieved, though efforts are being made to develop one.  A replication-defective HSV-2 mutant virus \u2013 the US strain HSV-2 dl5-29 \u2013 has been shown to induce immunity against the US strains HSV-2 G and 333 in mice and guinea pigs.  The potential benefits of an effective vaccine could be enormous in sub-Saharan Africa, where epidemiological studies have shown that genital herpes leads to a multi-fold increase in the risk of HIV transmission.<br \/>\nIn line with these ambitions, a recent study has sought to improve our knowledge of the genetic and epitope diversity of HSV-2, and its effect on vaccine efficacy, by testing HSV-2 vaccine candidates against HSV-2 strains derived from African, as well as, US isolates.  A first stage involved the testing of HSV-2 dl5-29 against both a panel of three US strains (G, 89-390, 186) and a panel of African strains (SD15, SD66, SD90).  HSV-2 dl5-29 proved effective against both US and African strains, though in the latter case equivalent protection required higher doses.  A second stage involved assessment of the ability of two replication-defective mutant viruses to protect against the same panels of US and African derived viruses \u2013  5BlacZ, deriving from a US strain, and SD90-8LacZ, deriving from an African one.  The US derived 5BlacZ tended to be more protective against US strains, and the African derived SD90-LacZ against African strains; at the same time, neither vaccine was as protective against the African strains as 5BlacZ was against the US ones, despite levels of humoral and cellular immune response that were equivalent in the US and African case.<br \/>\nThe authors draw two conclusions: first, that immune protection appears to be partially specific for the viruses from the US versus Africa; second, that the African HSV-2 viruses seem more virulent.  They call for further research in this area on account of its potential impact on the reduction of HIV transmission risk.<\/p>\n<p>Timothy E. Dudek, \u201cEvidence for Differences in Immunologic and Pathogenesis Properties of Herpes Simplex Virus 2 Strains From the United States and South Africa\u201d, Journal of Infectious Diseases 2011:203 (15th May)<\/p>\n<p><a href=\"http:\/\/jid.oxfordjournals.org\/content\/current\" target=\"_blank\">http:\/\/jid.oxfordjournals.org\/content\/current<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Still on the topic of HSV-2 &#8230; A clinically effective vaccine has yet to be achieved, though efforts are being made to develop one. A replication-defective HSV-2 mutant virus \u2013 the US strain HSV-2 dl5-29 \u2013 has been shown to induce immunity against the US strains HSV-2 G and 333 in mice and guinea pigs. [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":152,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2273],"tags":[],"class_list":["post-365","post","type-post","status-publish","format-standard","hentry","category-hsv-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Is African HSV-2 different ? - Sexually Transmitted Infections<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is African HSV-2 different ? - Sexually Transmitted Infections\" \/>\n<meta property=\"og:description\" content=\"Still on the topic of HSV-2 &#8230; A clinically effective vaccine has yet to be achieved, though efforts are being made to develop one. A replication-defective HSV-2 mutant virus \u2013 the US strain HSV-2 dl5-29 \u2013 has been shown to induce immunity against the US strains HSV-2 G and 333 in mice and guinea pigs. [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/\" \/>\n<meta property=\"og:site_name\" content=\"Sexually Transmitted Infections\" \/>\n<meta property=\"article:published_time\" content=\"2011-05-15T20:42:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Is African HSV-2 different ?\",\"datePublished\":\"2011-05-15T20:42:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/\"},\"wordCount\":367,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\"},\"articleSection\":[\"HSV-2\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/\",\"name\":\"Is African HSV-2 different ? - Sexually Transmitted Infections\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#website\"},\"datePublished\":\"2011-05-15T20:42:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2011\\\/05\\\/15\\\/is-african-hsv-2-different\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is African HSV-2 different ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\",\"name\":\"Sexually Transmitted Infections\",\"description\":\"Discussion and suggestion space for readers of STIs\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\",\"name\":\"Sexually Transmitted Infections\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/files\\\/2017\\\/10\\\/blog-logo-sti.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/files\\\/2017\\\/10\\\/blog-logo-sti.png\",\"width\":378,\"height\":34,\"caption\":\"Sexually Transmitted Infections\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is African HSV-2 different ? - Sexually Transmitted Infections","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/","og_locale":"en_US","og_type":"article","og_title":"Is African HSV-2 different ? - Sexually Transmitted Infections","og_description":"Still on the topic of HSV-2 &#8230; A clinically effective vaccine has yet to be achieved, though efforts are being made to develop one. A replication-defective HSV-2 mutant virus \u2013 the US strain HSV-2 dl5-29 \u2013 has been shown to induce immunity against the US strains HSV-2 G and 333 in mice and guinea pigs. [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/","og_site_name":"Sexually Transmitted Infections","article_published_time":"2011-05-15T20:42:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/"},"author":{"name":"","@id":""},"headline":"Is African HSV-2 different ?","datePublished":"2011-05-15T20:42:13+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/"},"wordCount":367,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/sti\/#organization"},"articleSection":["HSV-2"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/","url":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/","name":"Is African HSV-2 different ? - Sexually Transmitted Infections","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/sti\/#website"},"datePublished":"2011-05-15T20:42:13+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/sti\/2011\/05\/15\/is-african-hsv-2-different\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/sti\/"},{"@type":"ListItem","position":2,"name":"Is African HSV-2 different ?"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/sti\/#website","url":"https:\/\/blogs.bmj.com\/sti\/","name":"Sexually Transmitted Infections","description":"Discussion and suggestion space for readers of STIs","publisher":{"@id":"https:\/\/blogs.bmj.com\/sti\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/sti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/sti\/#organization","name":"Sexually Transmitted Infections","url":"https:\/\/blogs.bmj.com\/sti\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/sti\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/sti\/files\/2017\/10\/blog-logo-sti.png","contentUrl":"https:\/\/blogs.bmj.com\/sti\/files\/2017\/10\/blog-logo-sti.png","width":378,"height":34,"caption":"Sexually Transmitted Infections"},"image":{"@id":"https:\/\/blogs.bmj.com\/sti\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/sti\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts\/365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/users\/152"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/comments?post=365"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts\/365\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/media?parent=365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/categories?post=365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/tags?post=365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}